Home > Journals > Chirurgia > Past Issues > Chirurgia 2022 June;35(3) > Chirurgia 2022 June;35(3):133-7

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Chirurgia 2022 June;35(3):133-7

DOI: 10.23736/S0394-9508.21.05282-7

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Characteristics and prevalence of acute cholecystitis in patients with hematologic malignancies

Arwa Y. EL RIFAI 1, Majed W. EL HECHI 2, Karim M. NAJA 2, Hussein H. KHACHFE 2, Ali H. HALLAL 1

1 Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon; 2 Faculty of Medicine, American University of Beirut, Beirut, Lebanon



BACKGROUND: Acute cholecystitis is a serious medical condition that affects patients who are hospitalized. The purpose of this study was to describe the natural history of cholecystitis in patients who have lymphoproliferative diseases and to define risk factors and predictors of poor outcome.
METHODS: This is a retrospective study of patients admitted to the American University of Beirut Medical Center from January 2000 to December 2016 for chemotherapeutic treatment of hematologic malignancies and who developed cholecystitis during their hospitalization. The medical files were reviewed, and data related to demographics, management strategies and complications were collected.
RESULTS: Two thousand eighty-seven patients were admitted with hematologic malignancies. The most common malignancy was non-Hodgkin’s lymphoma, 42%. One thousand three hundred sixteen (88%) patients did not have gallstones while 181 (12%) had gallstones. Twenty-six out of the 181 patients who had gallstones (14%) developed cholecystitis while on chemotherapeutic treatment and eleven patients (6%) developed biliary colic requiring cholecystectomy. All mortality cases were in the non-surgical group and 70% were neutropenic at diagnosis. Cholecystectomies were performed more (P=0.002) in cases of calculous cholecystitis. Patients who developed acalculous cholecystitis had higher proportion of patients with fever (P=0.004), neutropenia (P=0.026), sepsis (P<0.001), need for respiratory support (P=0.015) and 30-day mortality (P=0.002).
CONCLUSIONS: Development of acute calculous and acalculous cholecystitis in patients with hematologic diseases has a significant impact on the treatment course. Cholecystectomy can be safely performed for these patients and was shown to have a better outcome than medical treatment.


KEY WORDS: Cholecystitis; Gallbladder; Hematology

top of page